Vericel (VCEL) Profit After Tax (2010 - 2026)
Vericel's (VCEL) quarterly Profit After Tax came in at -$6.3 million in Q1 2026, up 43.96% year-on-year from -$4.4 million in Q1 2025, and down 127.14% quarter-over-quarter from $23.2 million in Q4 2025.
Vericel (VCEL) Profit After Tax (2010 - 2026) Analysis & Trends
Vericel has disclosed Profit After Tax across 17 years of filings, most recently posting -$6.3 million for Q1 2026.
- Profit After Tax for Q1 2026 came in at -$6.3 million, up 43.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $21.4 million (up 619.85% YoY), and the FY2025 annual result was $16.5 million, up 59.41% from the prior year.
- Profit After Tax came in at -$6.3 million for Q1 2026 at Vericel, down from $23.2 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $23.2 million in Q4 2025 to a low of -$11.2 million in Q1 2025.
- The 5-year median for Profit After Tax is -$3.9 million (2024), against an average of $38941.2.
- Peak annual rise in Profit After Tax reached 663.15% in 2025, while the deepest fall reached 191.2% in 2025.
- Vericel's Profit After Tax stood at $5.9 million in 2022, then soared by 119.4% to $13.0 million in 2023, then jumped by 52.44% to $19.8 million in 2024, then advanced by 17.22% to $23.2 million in 2025, then sank by 127.14% to -$6.3 million in 2026.
- The last three Profit After Tax figures came in at -$6.3 million (Q1 2026), $23.2 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | -6.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.30 Mn |
| Dec 31, 2025 | 23.22 Mn |
| Sep 30, 2025 | 5.07 Mn |
| Jun 30, 2025 | -553,000.00 |
| Mar 31, 2025 | -11.25 Mn |
| Dec 31, 2024 | 19.81 Mn |
| Sep 30, 2024 | -901,000.00 |
| Jun 30, 2024 | -4.68 Mn |
| Mar 31, 2024 | -3.86 Mn |
| Dec 31, 2023 | 12.99 Mn |
| Sep 30, 2023 | -3.66 Mn |
| Jun 30, 2023 | -5.02 Mn |
| Mar 31, 2023 | -7.50 Mn |
| Dec 31, 2022 | 5.92 Mn |
| Sep 30, 2022 | -6.58 Mn |
| Jun 30, 2022 | -8.96 Mn |
| Mar 31, 2022 | -7.09 Mn |
| Dec 31, 2021 | 4.54 Mn |
| Sep 30, 2021 | -4.93 Mn |
| Jun 30, 2021 | -3.79 Mn |